SCHEMBL15549189

SCHEMBL15549189

NC(=O)C1(NS(=O)(=O)c2ccc(Br)c3ccccc23)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.47
FABP5 Q01469 1/20 0.46
BRD4 O60885 1/20 0.45
RXFP1 Q9HBX9 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD11B1 P28845 5/20 0.38
IKBKB O14920 1/20 0.37
LDHA P00338 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
MAPK10 P53779 1/20 0.35
PKM P14618 1/20 0.34
GAA P10253 1/20 0.34
HTT P42858 1/20 0.34
F2 P00734 1/20 0.33
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18077846 0.84 BRD4 (0.45) FABP4BRD4HSD11B1LDHACTSS
SCHEMBL16852627 0.84 BRD4 (0.47) FABP4BRD4HSD11B1CTSSCTSK
SCHEMBL21028150 0.82 BRD4 (0.51) FABP4BRD4HSD11B1CTSSCTSK
SCHEMBL21028102 0.81 BRD4 (0.45) FABP4FABP5BRD4HSD11B1CTSS
SCHEMBL15549456 0.76 BRD4 (0.42) BRD4HSD11B1CTSSCTSK
SCHEMBL16819769 0.74 PARG (0.47) FABP4FABP5RXFP1MEN1KMT2A
SCHEMBL28122139 0.73 HSD11B1 (0.55) HSD11B1
SCHEMBL2372449 0.70 MEN1 (0.46) FABP4FABP5RXFP1MEN1KMT2A
SCHEMBL14676620 0.70 POLB (0.46) HTT
SCHEMBL2372874 0.70 RXFP1 (0.54) FABP4FABP5RXFP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] PHENEX PHARMACEUTICALS AG (DE) 2019-05-28 US disclosed
US-20150175562-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA] PHENEX PHARMACEUTICALS AG (DE) 2015-06-25 US disclosed
EP-2855440-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA] Phenex Pharmaceuticals AG (DE) 2015-04-08 EP disclosed
WO-2013178362-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA] PHENEX PHARMACEUTICALS AG (DE) 2013-12-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175562-A1 CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA] RORA, RORB, RORC FABP4 1663/4885FABP5 496/4885BRD4 1075/4885
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] RORA, RORB, RORC FABP4 1424/4885FABP5 464/4885BRD4 982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.